Man Group PLC : Form 8.3 - Redrow plc
May 24, 2024 07:46 ET
|
Man Group PLC
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Satellite Optical Ground Station Markets to 2030 Featuring Strategic Analysis of GA-Synopta, Thales, Ball, AAC Clyde Space, and HENSOLDT
May 24, 2024 07:46 ET
|
Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Satellite Optical Ground Station Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
Understanding and Managing Contracts to Achieve Better Results (2-Day Virtual Course: September 26-27, 2024)
May 24, 2024 07:44 ET
|
Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Understanding and Managing Contracts to Achieve Better Results Training Course" training has been added to ResearchAndMarkets.com's offering. This...
Man Group PLC : Form 8.3 - Barratt Developments plc
May 24, 2024 07:43 ET
|
Man Group PLC
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Clinical Trial Monitoring 2-Day Online Training Course: July 29-30, 2024 - Understand the Importance of Compliance with the Latest GCP Standards
May 24, 2024 07:40 ET
|
Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trial Monitoring Training Course" conference has been added to ResearchAndMarkets.com's offering. With regulatory inspectors increasingly...
Man Group PLC : Form 8.3 - Tyman plc
May 24, 2024 07:40 ET
|
Man Group PLC
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Global Personalized Medicine Market Research Report 2024-2032 Featuring Abbott Laboratories, GE Healthcare, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche
May 24, 2024 07:39 ET
|
Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Global Personalized Medicine Market Report by Product, Application, End-Users, Region and Company Analysis 2024-2032" report has been added to ...
Life Science Technical Accounting CPE Update (2-Day Virtual Conference: September 17-18, 2024) - Understand the Latest Accounting Changes in Key Areas
May 24, 2024 07:32 ET
|
Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Life Science Technical Accounting CPE Update 2024" conference has been added to ResearchAndMarkets.com's offering. This conference will cover the...
United States BOPIS Analysis Report 2024: A $440+ Billion Market by 2032 from $111 Billion in 2023, Driven by Walmart, Home Depot, Kroger, Macy's, Kohl's, Costco, Best Buy, and Nordstrom
May 24, 2024 07:31 ET
|
Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "United States BOPIS Market Report by Product Category, Payment Method and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's...
BridgeBio Pharma to Present Additional Analyses from the Phase 3 ATTRibute-CM Study of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at the 2024 ISA Meeting
May 24, 2024 07:30 ET
|
BridgeBio Pharma, Inc.
- BridgeBio to host investor call on Wednesday, May 29, 2024 at 5:30 pm ET, with presentations from Mathew Maurer, M.D. of Columbia University Irving Medical Center, U.S. and Ahmad Masri, M.D., M.S....
- May 24, 2024 07:39 ET Global Personalized Medicine Market Research Report 2024-2032 Featuring Abbott Laboratories, GE Healthcare, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche
- May 24, 2024 07:31 ET United States BOPIS Analysis Report 2024: A $440+ Billion Market by 2032 from $111 Billion in 2023, Driven by Walmart, Home Depot, Kroger, Macy's, Kohl's, Costco, Best Buy, and Nordstrom